TBK Bank Announces Officer Promotions
DALLAS, Nov. 13, 2018 (GLOBE NEWSWIRE) — TBK Bank, SSB, a wholly owned subsidiary of Triumph Bancorp, Inc. (Nasdaq: TBK), […]
Aravive Presents Detailed Results of Phase 1 Clinical Trial of AVB-S6-500 at the 2018 EORTC-NCI-AACR Symposium
HOUSTON, Nov. 13, 2018 (GLOBE NEWSWIRE) — Aravive, Inc. (Nasdaq: ARAV), a clinical-stage biopharmaceutical company, today announced detailed results of […]
RedHill Biopharma Reports Third Quarter 2018 Financial Results and Business Highlights
Key Highlights: Top-line results from the confirmatory Phase III study with TALICIA® for H. pylori infection are on track to […]
Mersana Therapeutics Announces Third Quarter 2018 Financial Results and Provides Business Updates
XMT-1536 Phase 1 Dose Escalation Ongoing with Data Expected in the First Half of 2019 XMT-1522 Phase 1 Dose Escalation […]
Solid Biosciences Reports Third Quarter 2018 Financial Results And Provides Business Update
Two Additional Patients Dosed With SGT-001 Gene Transfer in IGNITE DMD Clinical Trial Company Plans to Report Preliminary Results from […]
MediWound Reports Third Quarter 2018 Financial Results
Awarded additional BARDA contract valued up to $43 Million for the development of NexoBrid® for sulfur mustard injuries Conference call […]
VBL Therapeutics to Report Third Quarter 2018 Financial Results on November 20
TEL AVIV, Israel, Nov. 13, 2018 (GLOBE NEWSWIRE) — VBL Therapeutics (Nasdaq: VBLT), a clinical-stage biotechnology company focused on the […]
Optinose Reports Third Quarter 2018 Financial Results and Recent Operational Highlights
Company reports third quarter net XHANCE revenue of $1.9 million Company reports 42% monthly XHANCE prescription growth from August to […]
U.S. FDA Accepts for Filing Shire’s Supplemental New Drug Application for GATTEX® (teduglutide [rDNA origin]) for Children with Short Bowel Syndrome
Intended for U.S. Audience U.S. FDA Accepts for Filing Shire’s Supplemental New Drug Application for GATTEX® (teduglutide [rDNA origin]) for […]
BeiGene Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., and BEIJING, China, Nov. 13, 2018 (GLOBE NEWSWIRE) — BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical […]
